Effectiveness of early awake self proning strategy in non-intubated patients with COVID-19 hypoxemia: an open-labelled randomized clinical trial from Jodhpur, India
Submitted: September 9, 2022
Accepted: December 5, 2022
Published: December 16, 2022
Accepted: December 5, 2022
Abstract Views: 1501
PDF: 396
Supplementary: 132
Supplementary 2_Ethics-Trial: 90
Supplementary 3-CONSORT Checklist: 127
Supplementary 4-Ministry of Health and Family Welfare handout: 91
Supplementary: 132
Supplementary 2_Ethics-Trial: 90
Supplementary 3-CONSORT Checklist: 127
Supplementary 4-Ministry of Health and Family Welfare handout: 91
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Matteo Vigna, Piero Ceriana, Mara Santomassimo, Michele Vitacca, Mauro Maniscalco, Nicolino Ambrosino, Effects of pulmonary rehabilitation in survivors of severe acute respiratory syndrome coronavirus 2. Role of vaccination , Monaldi Archives for Chest Disease: Early Access
- Anna Jacob, Kranti Garg, Kashish Dutta, Varinder Saini, Deepak Aggarwal, Ajeet Sidana, Role of detailed psychological evaluation and treatment in pulmonary rehabilitation programs for patients with chronic obstructive pulmonary disease , Monaldi Archives for Chest Disease: Early Access
- Lucrezia De Michele, Paola Pierucci, Guido Giovannetti, Michele De Ceglie, Michela Dimitri, Alessandra Mirabile, Vitaliano Quaranta, Arnaldo Scardapane, Carlo D'Agostino, Giovanna Elisiana Carpagnano, Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Anshul Mittal, Pranav Ish, Vidushi Rathi, Satish Kumar Kumawat, Shibdas Chakrabarti, JC Suri, Rehabilitation in obstructive sleep apnea: an ignored treatment adjunct , Monaldi Archives for Chest Disease: Early Access
- Ankit Lakra, Balbir Singh, Ashok Kumar Janmeja, Vanita Sharma, Arjun Kumar, A study to assess the relationship between vitamin D3 levels and the risk of acute exacerbation in patients with chronic obstructive pulmonary disease , Monaldi Archives for Chest Disease: Early Access
- Bineet Ahluwalia, Neeraj Kumar Gupta, Amitabh Singh, Pranav Ish, Nishanth Dev, Santvana Kohli, Rohit Kumar, Fellisha Marwein, Nitesh Gupta, Effect of COVID-19 vaccination status on outcome of adult patients admitted at a tertiary care centre in India , Monaldi Archives for Chest Disease: Vol. 93 No. 1 (2023)
- Luigi Pinto, Pietro Schino, Michele Bitetto, Ersilia Tedeschi, Michele Maiellari, Giancarlo De Leo, Elena Ludovico, Giovanni Larizza, Franco Mastroianni, Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia , Monaldi Archives for Chest Disease: Early Access
- Gabriella Bettelli, Bruno Neuner, Postoperative delirium: A preventable complication in the elderly surgical patient , Monaldi Archives for Chest Disease: Vol. 87 No. 2 (2017)
- Kiran B, Rupak Singla, Neeta Singla, Vinay V, Kuljeet Singh, Madhumita Paul Choudhury, Nilotpal Bhattacherjee, Factors affecting the treatment outcome of injection based shorter MDR-TB regimen at a referral centre in India , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Carlos A. Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A. Martinez Muñiz, Jacobo Sellarés, Maria A. Jiménez-Fuentes, Lourdes Lázaro Asegurado, Esther RodrÃguez Gonzalez, Concepción Rodriguez Garcia, Oriol Armengol, Emilia Abad, Teresa Peña, Adolfo Domenech del Rio, Juan A. Riesco Miranda, Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE study , Monaldi Archives for Chest Disease: Vol. 87 No. 3 (2017)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
You may also start an advanced similarity search for this article.